A new genomics laboratory opens in London to improve diagnostics for NHS cancer patients using “composite biomarker” testing. The facility is described as the first of its kind and is aimed at delivering a new generation of approaches to cancer diagnosis and care.
The testing approach combines information about a patient and their tumour, using artificial intelligence to build a broader picture of the cancer. By integrating multiple sources of biological and clinical data, the lab’s system is intended to support more precise diagnostic insights for clinicians working with NHS cancer services. Outlets agree on the lab’s purpose—upgrading cancer diagnostics—and the use of AI within the testing method, with some emphasis on the laboratory being unique in its role within the NHS and others highlighting how the composite testing merges patient and tumour data.
